HomeNNVC • NYSEAMERICAN
NanoViricides Inc
add
Market news
NDAQ
0.87%
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.25M | 17.86% |
Net income | -2.22M | -19.54% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.06M | -19.76% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.54M | -21.94% |
Total assets | 10.03M | -12.50% |
Total liabilities | 1.20M | 47.41% |
Total equity | 8.83M | — |
Shares outstanding | 16.07M | — |
Price to book | 2.44 | — |
Return on assets | -52.06% | — |
Return on capital | -58.51% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -2.22M | -19.54% |
Cash from operations | -1.99M | -2.44% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 575.50K | — |
Net change in cash | -1.42M | 28.80% |
Free cash flow | -1.23M | 10.56% |
Previous close
$1.34
Day range
$1.25 - $1.33
Year range
$0.94 - $2.55
Market cap
21.38M USD
Avg Volume
216.80K
P/E ratio
-
Dividend yield
-
About
Founded
2005
Headquarters
Website
Employees
7